CARE PROVIDERS There's an ongoing need to spread awareness and improve understanding of preeclampsia, even within the medical community. Our goal is to provide resources for patients and their...
"GAP—SPIRIN" is an evidence-based education campaign, encouraging the use of low-dose aspirin to help prevent preeclampsia and close the maternal health equity gap.
We urge healthcare providers to educate their patients about postpartum preeclampsia and ask them to remain vigilant to any symptoms post-delivery.
Strategic Roadmap to Address High Rates of Hypertension-related Maternal Mortality and Morbidity in Black Women
Hypertensive disorders of pregnancy (HDP) are a leading cause of maternal mortality and can put both mother and baby at risk for problems during pregnancy. Women who had HDPs have postpartum risk...
Although underlying causes of preeclampsia are not fully understood, there is evidence suggesting a strong genetic component. Genetic risk factors for blood pressure have been shown to contribute to...
High blood pressure (above 120/80 mm Hg) during pregnancy was linked to a greater chance of developing long-term health problems like diabetes, high cholesterol, high blood pressure, and heart disease...
Planned early-term delivery in individuals with mild chronic hypertension was not associated with a reduction in adverse maternal outcomes but was associated with an increase in some neonatal complica...
This study shows a link between preeclampsia and long-term brain health. Preeclampsia can affect the brain including experiencing changes in cognitive performance and a greater rate of cognitive decli...
Get Involved Getting Involved in the mission of the Preeclampsia Foundation can take several forms: volunteering locally or virtually, fundraising, donating in-kind or monetary support, sharing you...
What is Preeclampsia? Preeclampsia is a hypertensive disorder that occurs only during pregnancy and the postpartum period and affects both the mother and the unborn baby. Affecting at least...
GAP—SPIRIN campaign gets low-dose aspirin to those most at risk to help close the maternal health gap in preeclampsia ________ NEW YORK, January 23, 2025/PRNewswire/ – In recognition of...
While the Preeclampsia Foundation has been championing patient advocacy and representation for all families affected by hypertension in pregnancy throughout our 25 year history, we recognized the uniq...
Preeclampsia Foundation and Preeclampsia Foundation Canada have announced that Olivia Nonn, PhD, Mancy Tong, PhD, and Kelsey McLaughlin, PhD are their 2024 Vision Grant research award recipients. Thes...
Melbourne, FL – September 17 , 2024 – The Preeclampsia Foundation, in partnership with the International Society for the Study of Hypertension in Pregnancy (ISSHP) and Society for Ma...
August 5, 2024 – Melbourne, FL –– The Preeclampsia Foundation provided 100 Cuff Kits™, individual packages of self-measured blood pressure cuff and educational materials about...